1 month - $28.50

4 months - $102.00
Save $12.00

Insulin Resistance
A Lethal Link Between Metabolic Disease and Heart Attack

By William Davis, MD

Due to multimillion dollar advertising and marketing campaigns by the pharmaceutical industry, patients and physicians alike seem to associate heart attack and stroke risk only with cholesterol. Drugs that lower cholesterol (statins), have created a windfall of profit for pharmaceutical companies, with a single company’s statin drug often exceeding several billion dollars in annual sales. However, cardiovascular risk entails far more than just elevated cholesterol levels.

In fact, the phenomenon known as insulin resistance offers a direct link between metabolic disease and cardiovascular risk, and is an often overlooked culprit underlying diabetes and heart disease. Learn how and why these two common diseases are intimately related and how to untangle them from your life.

Sign Up For Our Free Email Newsletter

How are Blood Sugar and Plaque Related?

Diabetes and heart disease are intertwined from the start, sharing a complex panel of hidden phenomena that lay the foundation for both conditions. If diabetes is present, heart disease is much more likely to develop. If heart disease develops, it is far more likely that diabetes will also.

The shared misfortune of diabetes and heart disease emerged with Dr. Steven Haffner’s 1998 report from the University of Texas that people with diabetes who do not have heart disease have the same risk for heart attack as people with established heart disease—the risk is one and the same.1 In 1999, the American Heart Association went on to label diabetes “a cardiovascular disease.”

Since then, more studies have established this link. A 2001 study of people with stable heart disease but no previous history of diabetes found that approximately 50% of subjects had newly diagnosed disturbances of glucose metabolism (16% had full-blown diabetes and 36% had impaired glucose tolerance).2 Another recent study in persons hospitalized with more advanced, unstable heart disease symptoms (“unstable angina”) uncovered that 66% of those who met the criteria for diabetes were not diagnosed as such by their treating physician.3 In addition, the more extensive the heart disease identified, the higher the blood sugars tended to be. These insights provide us with strategies that could help diminish the likelihood of both diabetes and heart disease.


What You Need to Know: Insulin Resistance
  • Most people with heart disease and diabetes are insulin-resistant, which is a root cause of the metabolic syndrome that leads to the same destination—raised blood sugar, increased triglycerides, reduced HDL, heightened inflammation, and an increased risk of heart attack, stroke, and diabetes.

  • Diabetes and heart disease are intimately connected. Diabetics without heart disease have the same risk for heart attack as non-diabetics with established heart disease.

  • The first step in guarding against metabolic syndrome is to gauge the risk of insulin resistance through simple blood tests such as triglycerides, insulin, HDL, CRP, and DHEA.

  • Insulin resistance and inflammation can usually be reduced effectively without the need for prescription drugs by using the right nutritional supplement and lifestyle strategies.

  • Nutritional supplements that are effective for reducing insulin resistance include fish oil, chromium, white bean extract, DHEA, vitamin D, lipoic acid, magnesium, cinnamon, beta glucans, resveratrol, and polyphenols found in cocoa, green tea, and apples.

Insulin Resistance—Root of the Problem

The majority of people with heart disease and diabetes have, often buried years earlier in their past, a pattern of poor responsiveness to insulin, or “insulin resistance.” Once this phenomenon becomes established, the stage is set.

Insulin is the hormone that helps the cells and tissues of the body use glucose. An autoimmune process, whereby the body’s immune system attacks the insulin-producing cells of the pancreas, is the defect behind type 1 diabetes. This is a different process from so-called ‘adult-onset’, or type 2, diabetes.

Type 2 diabetes in adults represents a metabolic imbalance of both insulin secretion and insulin action at the cellular level, as opposed to the absolute deficiency of insulin observed with type 1 diabetes. In patients with type 2 diabetes, a number of factors lead to a poor response to insulin in muscle, fat, and liver. In essence, tissue cells become less responsive to insulin. This triggers the pancreas to overcompensate by producing greater quantities of insulin. Blood levels of insulin double, triple, even quadruple as the pancreas struggles to overpower the body’s poor responsiveness to insulin. This is the situation called “insulin resistance.”

For reasons that have yet to be understood, an overworked pancreas cannot meet the increased demand for insulin for long. After just a few years, the insulin-producing beta cells of the pancreas begin to “burn out” and blood sugar rises. Rising blood sugar is therefore a sign of insulin resistance.

Insulin resistance is present in 90% or more of people with diagnosed diabetes.4 In all practicality, adult-onset, or type 2, diabetes is synonymous with poor sensitivity to insulin.

Insulin resistance is an underlying cause of a number of metabolic abnormalities that are grouped together in a condition called the metabolic syndrome. This disorder is associated with a host of undesirable consequences such as rising blood sugar, increased triglycerides, which lead to a reduction in beneficial high-density lipoprotein (HDL) and an increase in dangerous, small low-density lipoprotein (LDL) particles, greater risk for blood clotting, and high blood pressure.4,5

The list of metabolic phenomena triggered by insulin resistance should appear familiar—these are also risk factors for coronary atherosclerosis.4

C-Reactive Protein (CRP)—What is it?

A high CRP means that inflammatory processes are active in your body. You might have an obvious source, like a recent bout of viral bronchitis, painful arthritis in your left knee, or gout in the right big toe. However, an increased CRP also tells you and your doctor that inflammation may be active in your blood vessels.

Increased CRP (>3.0 mg/L) doubles or triples heart attack risk, regardless of LDL levels.80 When CRP is high, coronary atherosclerotic plaque is more prone to rupture, the feared event that triggers a heart attack. When high CRP occurs in the company of small LDL particle size, one of the phenomena associated with insulin resistance (a lipoprotein measure,81 the risk of a heart attack risk is nearly seven-fold greater.82

C-reactive protein must be viewed in the context of other measures of health and disease. If elevated, the risk of multiple conditions escalates.

More About Metabolic Syndrome

Metabolic syndrome is known by a number of different names—insulin resistance syndrome, syndrome X, borderline diabetes, among others and is typically associated with increased triglycerides, reduced HDL, heightened inflammation, three-fold or greater risk of heart attack,6 greater risk for stroke, and diabetes.

Metabolic syndrome can drive the growth of atherosclerotic plaque even when everything else, like LDL, is corrected to perfect levels. Even with excellent LDL levels, for instance, hidden atherosclerotic heart disease can continue to grow at an alarming rate.

The first step in guarding against insulin resistance and metabolic syndrome is to gauge one’s risk through simple tests such as triglycerides, insulin, blood pressure, HDL, C-reactive protein, and dehyroepiandro-sterone (DHEA). You and your doctor should suspect insulin resistance and metabolic syndrome if:

  • HDL is <50 mg/dL in women, <40 mg/dL in men

  • Triglycerides are >150 mg/dL

  • Blood pressure exceeds 130/85 mmHg

  • Fasting blood sugar is >100 mg/dL

  • There is excess abdominal fat.

The likelihood of developing metabolic syndrome also escalates sharply above a body mass index (BMI) of 27. Keep in mind that these cut-offs are somewhat arbitrary and that lesser degrees of insulin resistance can be present before these cut-off points are fully reached.

Some leading researchers advocate detecting risk of insulin resistance and metabolic syndrome by measuring waist size. If waist circumference is >35 inches in a female or >40 inches in a male, then metabolic syndrome is a high risk.7,8

Insulin Resistance and Inflammation

Insulin resistance is also associated with inflammation, as reflected by increased levels of the inflammatory markers nuclear factor-kappa B, interleukin-6, and C-reactive protein (CRP).5,9 C-reactive protein is the blood test that has emerged as a valuable tool to gauge hidden, imperceptible inflammation. Studies have consistently shown that the higher the CRP, the brighter the flame of inflammation that burns in the body and the greater the likelihood of heart attack and diabetes.10-12

In addition, insulin resistance triggers abnormalities in a recently recognized group of signaling molecules called adipokines.13 Fat cells, particularly those in the abdomen (“central obesity”), assume a life of their own and begin to act just like an independent new organ of the body, producing dozens of these unique substances. The adipokine, leptin, for instance, is produced by abdominal fat cells and causes white blood cells called macrophages to grab cholesterol particles, a phenomenon believed to add to coronary atherosclerosis. Tumor necrosis factor-alpha (TNF-alpha), another potent adipokine, activates inflammatory responses in vascular tissue and increases release of adhesive molecules, both of which add to atherosclerosis.5,14,15 Increased adipose tissue mass contributes to increased secretion of proinflammatory cytokines, especially TNF-alpha.15

Increasing Insulin Sensitivity and Reducing Inflammation

The key to reducing or eliminating many of the threats of both metabolic syndrome/insulin resistance and heart disease is to chip away at the root cause of both and increase insulin sensitivity. Correct this fundamental defect and correction of multiple other phenomena will follow—HDL will increase, small LDL particles will be reduced, and triglycerides will plummet. The blood-clotting protein fibrinogen will also drop while physical stamina and energy will increase.

Likewise, hidden inflammation that fuels both heart disease and metabolic syndrome will be powerfully reduced.

In most cases, insulin resistance, inflammation, and CRP can usually be reduced effectively and dramatically—usually to normal—just by using the nutritional supplements and lifestyle strategies discussed below. Furthermore, achieving glycemic control in patients with insulin resistance through lifestyle and nutritional interventions can effectively prevent or delay the development of cardiovascular problems and complications.

As you will read, given the right kind of information, drugs are not always necessary, perhaps rarely.

Lifestyle strategies that help correct insulin sensitivity, reduce hidden inflammation (CRP), and thereby contribute to reducing the likelihood of heart disease and diabetes include:

Exercise. For improvement of insulin sensitivity, at least 30 minutes of physical activity per day is required for benefit, preferably 60 minutes. Also, the more frequent your efforts, the better. Exercise can scale down inflammation, as well. An Israeli experience in 28 patients with coronary heart disease showed that 12 weeks of aerobic exercise at 70–80% of maximum heart rate reduced CRP by 19% in non-diabetics and by 40% in diabetics.16 Strength training with weights or resistance machines also helps by increasing basal metabolic rate and accelerating fat loss. Twenty minutes twice a week of strength training can accelerate progress tremendously.

Weight loss (if overweight). Weight loss yields the most dramatic effect of all for both improving insulin response and reducing inflammation. Weight reduction yields dramatic drops in CRP.17-19 The principal determinant is the amount of weight lost, not the means by which you achieve it.18–20

Healthy foods. Choose foods rich in soluble fiber and lower in glycemic load (i.e. the total amount of sugar and carbohydrate calories). The best foods are raw nuts and seeds, oat bran, lean proteins, and omega-3 fatty acids. Some dietary approaches may pack a greater effect than others (see below). Dietary strategies such as replacing saturated fat with healthy oils like olive, canola, and flaxseed (for monounsaturates); selecting lower glycemic-load foods such as lean proteins, whole grain products, and vegetables; and avoiding foods like processed white flour and white sugar-laden foods like cookies, crackers, candies, and cakes will help subdue inflammation and improve insulin response.21-23

The Mediterranean diet is one effective approach to improve insulin responses and reduce inflammation. The Greek ATTICA Study of over 3,000 men and women yielded 20% reduction of CRP in participants who most closely adhered to a traditional Mediterranean diet. The diet includes plentiful olive oil (a rich source of monounsaturated fat), vegetables and fruits, nuts, and fish, with little or no processed foods.24 Several other studies have demonstrated improvement in insulin responses and reduction of blood sugar on the Mediterranean diet.23,25,26

A major boost in soluble fiber intake may also increase success in reducing inflammation and insulin responses. David Jenkins, MD, PhD, DSc, at the Clinical Nutrition & Risk Factor Modification Center in Toronto has acquired a fascinating experience using an approach he calls “the dietary portfolio” of cholesterol-lowering foods.

In one study, 46 participants followed a four-week nutrition program that added the following nutrients per 1,000 kcal of subjects’ total intake: 1.0 gram of phytosterols (high in plant sterols), 9.8 grams viscous, or soluble, fibers such as oat bran and oat products, barley, and psyllium seed, 21.4 grams soy protein, and 14 grams raw almonds. (An average 2,400 kcal diet would provide 2.4 grams phytosterols, 24 grams viscous fiber, 51 grams soy protein, and 34 grams almonds.) Participants averaged a fiber intake of 78 grams/day, which is five times more fiber than the average American consumes.27 A control group followed a very low saturated fat, dairy, and whole grain cereal diet, rather than foods containing viscous fibers and plant sterols.28

Dr. Jenkins’ dietary portfolio achieved an LDL reduction of 29% and a 28% reduction in CRP, compared with the control group who achieved only 8% reduction in LDL and 10% reduction in CRP. Another treatment group on the control diet received treatment with the cholesterol drug, lovastatin (Mevacor®), but performed no better than the dietary portfolio group.28

Dr. Jenkins’ dietary portfolio and other studies have also shown that abundant fiber intake, especially viscous or soluble fibers, slows the release of sugars into the bloodstream and thereby blunts excessive insulin responses. Improvements in insulin sensitivity and blood glucose responses have also been demonstrated in several other studies.29,30

Sleep. Chronic lack of a full night’s sleep impairs insulin function and contributes to the visceral (within abdominal contents) fat accumulation peculiar to metabolic syndrome.31 Maintaining seven to eight hours of sleep per night helps enhance insulin responses.31,32 Melatonin supplementation to restore normal sleep-wakefulness cycles may help improve metabolic syndrome and inflammation.33

What is Your Level of Insulin Resistance?

A blood glucose meter can be a useful addition to your home health tools. Manufacturers often provide a coupon to cover the cost of the meter, though single-use test strips run about $1 each.

According to the American Diabetes Association,83 if the blood is tested after an overnight fast and the number reads:

  • >126 mg/dL – See your doctor for confirmation as 126 mg/dL is the cut-off for diagnosis of diabetes.

  • 100–125 mg/dL – Impaired fasting glucose (IFG) may be present, meaning that the cells of your body are becoming insulin-resistant.

  • 100–110 mg/dL – A gray zone. Not perfect but not yet into the official range of insulin resistance or IFG. If this is your reading, then now is the time to start taking action to prevent metabolic disease from materializing.84

  • <100 mg/dL – “Normal” (ideally, Life Extension researchers and scientists believe that fasting blood sugar should be in the range of 70-85 mg/dL for optimal longevity).

Since insulin resistance triggers the pancreas to overproduce insulin, measuring the fasting insulin level can also identify resistance to its effects. Levels will be high, usually >10 µU/mL, though often 30, 40 or higher, even when glucose is normal (<100 mg/dL).

What are the Odds?

The National Health and Nutrition Examination Survey in 1999-2002 showed that:85

  • One-third of adults with diabetes don’t know they have it. That adds up to over 6 million people.

  • Of the total US population, one in four adults has impaired fasting glucose (IFG) and the proportion increases with age.

  • Up to 35% of US adults have either diabetes (diagnosed and undiagnosed) or IFG.

And the numbers are growing as Americans become more overweight and sedentary.85

Nutritional Supplements

The following supplements can help reduce insulin resistance and inflammation in the body:

Fish oil. Omega-3 fatty acids contained in fish oil help in numerous ways.34 Omega-3s effectively reduce the inevitably elevated triglycerides of metabolic syndrome, raise HDL, and reduce inflammation.35-38 Of all their benefits, the triglyceride-reducing power of omega-3s represents their most powerful effect, which is likely responsible for the dramatic reduction in heart attack and stroke seen with supplementation.39-41 Approximately 1,400 mg eicosapentaenoic acid and 1,000 mg docosahexaenoic acid are recommended each day for maintaining a healthy heart.

Chromium. Doses of supplemental chromium ranging from 200 mcg/day to 1,000 mcg/day improve blood sugar by enhancing the effects of insulin.42,43 Chromium supplements also offer a useful adjunct to diabetic patients on sulfonylurea therapy, which is normally associated with weight gain when taken alone. In a recent study in adult diabetics, the usual weight gain seen with sulfonylurea therapy was significantly reduced by supplementing with chromium picolinate, 1,000 mcg/day.43 Other studies have demonstrated that chromium supplementation safely reduces cholesterol and triglyceride levels, and may reduce requirements for oral antidiabetes medication.44

White bean extract. This extract of the common white bean, Phaseolus vulgaris, is a starch blocker that blocks intestinal carbohydrate absorption by up to 66%. A recent randomized, placebo-controlled study showed that 445 mg of white bean extract twice daily in overweight adults led to 6.4 pounds of weight loss (while maintaining lean body mass) after 30 days compared with only 0.8 pounds in non-treated subjects.45

White bean extract also improves insulin responses by reducing sugar absorption and through weight loss.45

DHEA. When taken at bedtime, this adrenal gland hormone enhances mobilization of abdominal fat that contributes to metabolic syndrome, insulin resistance, and inflammation.46 Life Extension recommends the usual dose range for aging men and women is 15-75 mg daily. Ideally, DHEA-S blood levels should be obtained three to six weeks after dosing to assess individual response.46 Men and women with hormone-responsive cancers should only supplement with DHEA after clearance by their personal physician.

Vitamin D. Numerous exciting reports about vitamin D’s myriad beneficial effects include recent observations that vitamin D deficiency contributes to insulin resistance and raises blood pressure (by increasing the blood pressure-raising hormone renin).47 Vitamin D deficiency is exceedingly common, particularly in northern climates, where up to 90% of people have moderate-to-severe deficiency. In sun-deprived climates, 1,000–4,000 IU/day may be required to raise blood levels to normal, occasionally more. Most people who lack sun exposure can safely take 2,000 IU/day.48 However, adequate sun exposure does not necessarily guarantee optimal vitamin D levels.49 Vitamin D status can be assessed by having one’s blood tested. Optimal levels are considered to be in the range of 30-50 ng/mL (75-125 nmol/L) of 25-hydroxyvitamin D in the blood. (Discuss vitamin D supplementation with your doctor if you have kidney disease, kidney stones, or a history of high calcium levels.)

Vitamin D is also gaining recognition as a crucial modulator of inflammation. A University of London study demonstrated a dramatic reduction in the inflammatory proteins CRP and matrix metalloproteinase (MMP), after supplementation in 171 healthy adults, with a startling 68% reduction in MMP.50

Magnesium. This mineral is needed for more than 300 biochemical reactions and is recognized as an important mediator of insulin action and in reducing inflammation. In several studies, daily oral magnesium supplementation substantially improved insulin sensitivity by 10% and reduced blood sugar by 37%.51-53 The Women’s Health Study including nearly 12,000 participants showed that people who fail to take the recommended adequate intake of magnesium of 320-420 mg/day are more prone to have both metabolic syndrome and increased CRP.54 Improved sensitivity to insulin generated by magnesium replacement can dramatically reduce triglycerides by as much as 75 mg/dL.53 Reduced triglyceride availability, in turn, reduces the triglyceride-rich particles, very low-density lipoprotein (VLDL) and small LDL, which are powerful contributors to heart disease. Magnesium supplementation can also raise levels of beneficial HDL.55,56

Magnesium deficiency is common not only from a dietary standpoint, but is also becoming an even larger issue as people turn to bottled water, which contains hardly enough magnesium, and as municipal water treatment more intensively “softens” its water by removing magnesium.

Even the federal government admits that many Americans do not obtain the recommended amount of magnesium, which is 320 mg/day for women and 420 mg/day for men.57 Magnesium supplementation is therefore a basic requirement for health for most people. (Discuss this with your doctor if you have kidney disease or electrolyte disorders.)

Flavonoids. Naturally occurring flavonoid compounds are important for suppressing inflammation. Emerging research suggests that some flavonoids also enhance insulin response and reduce insulin resistance. Of the thousands of known flavonoids identified, several, including polyphenols and resveratrol, stand out for these benefits.

Polyphenols derived from green tea, cocoa, and apples are emerging as powerful facilitators of insulin responses as well as being potent anti-inflammatory compounds.58-60 A study comparing the effects of dark chocolate, containing beneficial cocoa polyphenols, with white chocolate (non-cocoa), 100 grams per day for 15 days, showed that only dark chocolate improved insulin sensitivity.61 Another study in 10 healthy volunteers showed that 37 grams of dark chocolate (containing 148 mg of procyanidins) yielded a 29% decrease in inflammatory leukotrienes and a 32% increase in the anti-inflammatory prostacyclin compared with subjects who received chocolate containing only 33 mg of procyanidins.58 This net decrease in the plasma leukotriene-prostacyclin ratio, a measure of proinflammatory-anti-inflammatory eicosanoid balance, dissipated six hours after subjects ingested the chocolate, suggesting that consumption of flavonoid sources several times a day is more likely to yield maximum benefit.58

Cocoa polyphenols also work in synergy with beta glucans, which offer an excellent source of low-glycemic carbohydrates. Beta glucans are an excellent form of soluble dietary fiber that help modulate the body’s response to carbohydrate-containing foods,62-64 promote satiety and weight loss,65 and lower CRP levels.66

Researchers have also found that cinnamon helps to diminish the dangerous after-meal surge in blood glucose,67 due to water-soluble polyphenols contained in this spice.68

Resveratrol, a flavonoid found in grape skins and concentrated in red wine, has also attracted a good deal of research attention. Red wine, 12 oz/day, has been found to improve insulin responses in people with diabetes. Resveratrol suppresses inflammatory mediators and powerfully inhibits matrix metalloproteinase, a trigger for atherosclerotic plaque rupture that results in heart attack and stroke.69 In data extrapolated from animal studies, resveratrol doses of at least 20 mg/day are necessary to protect against heart disease.70 A glass of red wine (about 6 oz or 180 mL) averages just 500 mcg of resveratrol.71 In addition, resveratrol content in red wines varies enormously depending on type of grape, soil characteristics, methods of barreling, etc., but averages around only 2.5 mg/L.71 Non-drinkers and those seeking protection for a healthy heart can obtain resveratrol as a standalone supplement, or mixed with other flavonoids.

The powerful antioxidant supplement, lipoic acid, is also a useful strategy to curtail inflammatory responses and improve insulin responses.72-78 Although much of the research on lipoic acid 600-1,800 mg/day has focused on the improvement of painful nerve conditions associated with type 2 diabetes, lipoic acid also suppresses inflammatory mediators, such as interleukin-6 and plasminogen activator-1.79

Break the Insulin Resistance Connection and Lower Your Risk of Heart Disease and Diabetes

Choosing low glycemic-load foods rich in soluble fiber, getting a full night’s sleep as consistently as possible, exercise, and taking nutritional supplements like fish oil, vitamin D (especially if you are sun-deprived), lipoic acid, magnesium, cinnamon, beta glucans, resveratrol, and polyphenols found in cocoa, green tea, and apples are part of a powerful integrative plan for breaking the insulin resistance connection.

You can chart your progress by periodically measuring a variety of important metabolic and cardiovascular factors.

You want to achieve:

  • Fasting blood glucose: <100 mg/dL

  • C-reactive protein: < 0.55 mg/L for men and <1.5 mg/L for women

  • Fasting blood triglycerides: <100 mg/dL

  • Blood HDL: >40-50 mg/dL for men and >50 mg/dL for women

  • Waist circumference: <40 inches for men and <35 inches for women.

If you have had a lipoprotein analysis, e.g., a VAP® (vertical auto profile) or NMR (nuclear magnetic resonance) test, reducing small LDL to <15% of total LDL can be a helpful secondary measure. Achieving a blood pressure of ≤130/85 mmHg is another important goal.

Remember, decreasing heart disease risk is far more than simply taking a statin drug or making sure that your LDL is within an optimal range. By focusing on improving insulin sensitivity, you can help reduce the risk of heart attack and break the lethal connection between cardiovascular and metabolic diseases!

Dr. William Davis is a practicing cardiologist in Milwaukee, Wisconsin. He is founder of the Track your Plaque program, a heart disease prevention program that shows how to use CT heart scans to control coronary plaque. He can be contacted through www.TrackYourPlaque.com.

If you have any questions on the scientific content of this article, please call a Life Extension Health Advisor at 1-800-226-2370.

CinSulin® with InSea2™ and Crominex® 3+
90 vegetarian capsules
Item Catalog Number: 01503

Dietary carbohydrates are nearly impossible to avoid in  today’s "grab-and-go" world.  The result?  Countless aging Americans find themselves  under assault from excess glucose calories. Even health-conscious, active  people can experience higher-than-desired blood sugar levels as they age. Life Extension® now offers an  enhanced, all-natural, multipronged approach to this challenge, called CinSulin® with Insea2™  and Crominex® 3+.

Excitement has been building among researchers around the world  over the clinically demonstrated power of a novel form of cinnamon to support healthy  glucose metabolism. Scientists at the US  Department of Agriculture have been quietly studying it for more than a decade.1,2  Government experts have been amazed by compelling in vitro results documenting  its ability to induce a twenty-fold increase  in sugar metabolism.3

Studies in humans have proven just as impressive. In a  recent double-blind, placebo-controlled clinical trial,4 a group of maturing  individuals (average age 61) taking 500  mg per day of the cinnamon extract contained in the new CinSulin® formula experienced an  average decline of 12 mg/dL in fasting blood  glucose after only two months. This novel cinnamon extract also produced a  significant decrease in after-meal glucose  spikes (an average of 32 mg/dL) after ingestion of 75  g of carbohydrates!

An objective of those who practice calorie restriction is to maintain fasting glucose levels at around 80 mg/dL of blood and after-meal glucose spikes to no  greater than 40 mg/dL.  CinSulin® may help more longevity enthusiasts accomplish their  glucose control objective.

The danger with cinnamon is the presence of naturally occurring, toxic  fat-soluble compounds known as aldehydes.   Life Extension® has identified a highly purified "type-A" water-soluble  cinnamon extract using a patented process that eliminates these dangerous  toxins.

Researchers have known of the many health benefits of seaweed extracts for years.  Only recently has it come to light that a  proprietary form of seaweed extract  called InSea2™ blocks the action  of glucosidase and amylase—enzymes your body uses to break down carbohydrates into glucose,  facilitating its transport into the bloodstream.

Derived from brown  seaweed and bladderwrack,  a single 500 mg dose of  this proprietary compound triggered a 48.3% decline in after-meal blood sugar spikes in a recent double-blind,  placebo controlled trial.5

Long known for its role in maintaining healthy glucose metabolism,  chromium has been optimized with  standardized extract of Indian  gooseberry and a proprietary form of the adaptogen shilajit. The name of this most advanced chromium complex is Crominex® 3+. The Crominex® 3+ complex helps support:

  • Normal cellular glucose absorption6-10
  • Healthy endothelial function11,12
  • Healthy lipid and triglyceride levels13-16
  • Normal cellular energy production17,18

Combined with CinSulin®  and Insea2™, the result is an  unrivalled formula that affords optimal support for healthy glucose metabolism  in aging individuals.

Supplement Facts

Serving Size 1 vegetarian capsule

Servings Per Container 90

Amount Per Serving

Iodine (typical value naturally occurring from Ascophyllum nodosum and Fucus vesiculosus)

37.5 mcg

Chromium [as Crominex® 3+ chromium stabilized with Capros® standardized Phyllanthus emblica extract (fruit) and PrimaVie® purified and standardized Shilajit] 133 mcg

CinSulin® Cinnamon (Cinnamomum cassia) water extract (bark) [standardized to 2.5% (4.375 mg) Type-A Polymers]

175 mg

InSea2™ [proprietary composition of demineralized polyphenols from brown seaweeds Kelp (Ascophyllum nodosum) and Bladderwrack (Fucus vesiculosus)] 100 mg

Other ingredients: rice flour, vegetable cellulose (capsule), vegetable stearate.

Contains rice.
This product contains NO milk, egg, fish, peanuts, crustacean shellfish (lobster, crab, shrimp), soybeans, tree nuts, wheat, yeast, gluten or corn. Contains NO sugar and no artificial sweeteners, flavors, colors, or preservatives.

Crominex®3+, Capros® and PrimaVie® are registered trademarks of Natreon, Inc.
CinSulin® is a registered trademark of Tang-An Medical Ltd., manufactured under US patent #6,200,569.
InSea2™ is a trademark of innoVactive™.


Dosage and Use

Take one capsule 20-30 minutes before each meal not exceeding three capsules daily, or as recommended by a healthcare practitioner.


Because this product may lower blood glucose, consult your healthcare provider before taking this product if you are taking blood glucose lowering medication.


Top References

Glucose Management

1. Diabetes Care. 2003 Dec;26(12):3215-8.
2. Diabetes Obes Metab. 2007 Nov;9(6):895-901.
3. J Trace Elem Med Biol. 2006;20(1):33-9.
4. Biofactors. 2007;31:201-10. 
5. Ann Intern Med. 2004 Jan 6;140(1):1-8.
6. J Nutr Biochem. 2002 Dec;13(12):717-26.
7. Am J Clin Nutr. 2003 Oct;78(4):728-33.
8. Med Hypotheses. 2005;64(4):848-53.
9. BMC Pharmacol. 2004 Aug 26;4:18. 
10. Diabetes Res Clin Pract. 2006 Aug;73(2):174-7.
11. J Nutr Sci Vitaminol (Tokyo). 2008 Jun;54(3):266-8.
12. Life Sci. 2006 Nov 25;79(26):2474-9.
13. Nature Med. 2003 Mar;9(3):294-9.
14. Postepy Hig Med Dosw (Online). 2008 Sep 5;62:451-62.
15. Diabetes Care. 2006 Sep;29(9):2064-71.
16. Ann N Y Acad Sci. 2005 Jun;1043:777-83.
17. Diabetes Metab Res Rev. 2004 Jul-Aug;20(4):330-6.
18. Diabetes. 2003 Aug;52(8):2110-20.
19. Acta Diabetol. 2001;38(3):135-8.
20. Diabetes. 2006 Aug;55(8):2231-7.
21. Ann N Y Acad Sci. 2005 Jun;1043:784-92.
22a. J Lipid Res. 2006 May; 47(5): 964-74
22b. Biochem Biophys Acta. 2001 Feb 14;1535(2):110-9
22c. J Am Soc Nephrol. 2005 Jan;16(1):144-50.
22d. Life Sci. 1988;43(21):1725-31.
23. Rev Med Interne. 2007 Dec;28(12):832-40
24. Ann N Y Acad Sci. 2005 Jun;1043:529-32.
25. Am J Clin Nutr. 2007 Mar;85(3):709-17.
26. Hypertension. 2005 Aug;46(2):398-405.
27. Heart. 2006 Jan;92(1):119-20.
28. Free Radic Biol Med. 2004; 37: 1351–1359.
29. Am J Clin Nutr. 2005 Jan;81(1 Suppl):304S-312S
30. JAMA. 2007 Jul 4;298(1):49-60.
31. J Nutr. 2008 Sep;138(9):1671-6.
32. Am J Clin Nutr. 2005 Mar;81(3):611-4.
33. J Nutr. 2007 Jun;137(6):1436-41.
34. Nutrition. 2007 Apr;23(4):332-41.
35. Altern Ther Health Med. 2005;11(6):30-4.
36. J Am Coll Nutr. 2003 Feb;22(1):36-42. 
37. Nutr Hosp. 2004 Jan-Feb;19(1):45-50.
38. Sci Total Environ. 1981 Jan;17(1):13-29.
39. 10th International Congress of Toxicology-Finland. 2004 July;197:abs. 354.
40. Mol Cell Biochem. 2003 Oct;252(1-2):369-77
41. Metabolism 1997;46:469-73.
42. J Med. 2000;31(5-6):227-46.
43. Biol Trace Elem Res. 1996 Dec;55(3):297-305.
44. Horm Metab Res. 2007 Oct;39(10):743-51.
45. Am J Physiol Heart Circ Physiol. 2006 Aug;291(2):H820-6.
46. Med Sci Sports Exerc. 1997 Aug;29(8):992-8.
47. J Pineal Res. 2003 May;34(4):269-77.
48. Biochem Biophys Res Commun. 2003 Oct 3;309(4):1017-26.
49. J Clin Biochem Nutr. 2008 Nov;43(3):191-8.
50. Biol Pharm Bull. 2004 Jul;27(7):1103-5.
51. J Ethnopharmacol. 2003 Jul;87(1):115-7.
52. Biosci Biotechnol Biochem. 1996 Feb;60(2):204-8.
53. J Nutr Sci Vitaminol (Tokyo). 1999 Dec;45(6):791-5.
54. J Nutr. 2001 Sep;131(9):2242-7.
55. Chem Pharm Bull (Tokyo). 1993 Dec;41(12):2129-31.
56. Diabetes Res Clin Pract. 2006 Aug;73(2):174-7.
57. Biol Pharm Bull. 2006 Mar;29(3):585-7.
58. Life Sci. 2006 Nov 25;79(26):2474-9.
59. Eur J Pharm Sci. 1999 Apr;8(1):57-65.
60. Free Radic Biol Med. 1999 Mar;26(5-6):685-94.
61. Biochem Mol Biol Int. 1998 Oct;46(3):585-95.
62. Am J Physiol. 1997 Jul;273(1 Pt 1):E185-E191.
63. Diabetes. 1996 Dec;45(12):1798-804.
64. Biochem Biophys Res Commun. 1996 Apr 16;221(2):422-9.
65. Biochem Pharmacol. 1996 Feb 9;51(3):233-8.
66. J Mol Cell Cardiol. 1995 Sep;27(9):1895-903.
67. Skin Pharmacol. 1994;7(5):278-84.
68. Z Naturforsch [C]. 1994 Sep-Oct;49(9-10):691-2.
69. Carlson DA, et al. Lipoic Acid: Energy Production, Antioxidant Activity and Health Effects. Taylor & Francis Publishers; 2008:235-70.
70. Med Rev. 2007 Dec;12(4):343-51.


Bottom References

1. J Agric Food Chem. 2000 Mar; 48(3):849–52.
 2. Phytomedicine. 2010 May 27.
 3. J Agric Food Chem. 2004 Jan 14;52(1):65-70
 4. FASEB J. 2010; 24:722.1.
 5. J Metab. Submitted for publication.
 6. Diabetes Res Clin Pract. 1995 Jun;28(3):179-84.
 7. Diabetes. 1997 Nov;46(11):1786-91.
 8. Ned Tijdschr Geneeskd. 2004 Jan 31;148(5):217-20.
 9. Altern Med Rev. 2002 Jun;7(3):218-35.
 10. Saudi Med J. 2000 Jan;21(1):45-50.
 11. Br J Nutr. 2007 Jun;97(6):1187-95.
 12. Yakugaku Zasshi. 2005 Jul;125(7):587-91.
 13. J Ethnopharmacol. 2002 Jan;79(1):81-7.
 14. J Nutr Sci Vitaminol (Tokyo). 2005 Dec;51(6):413-8.
 15. Yakugaku Zasshi. 2007 Feb;127(2):385-8.
 16. Indian J Exp Biol. 2001 Aug;39(8):760-6.
 17. Indian J Exp Biol. 1997 Mar;35(3):297-9.
 18. Phytother Res. 2007 May;21(5):401-5.

The information herein is not intended to replace the medical advice of your physician. You are advised to consult with your physician with regards to matters relating to your health, and in particular regarding matters that may require diagnosis or medical attention. DO NOT stop taking medications without first consulting with your physician. These statements have not been evaluated by the Food and Drug Administration.Every effort has been made to ensure that the information provided herein is accurate, up-to-date, and complete, but no guarantee is made to that effect. This information has been compiled for use by healthcare practitioners and consumers in the United States. Heart 2 Heart of America does not endorse drugs, diagnose patients or recommend therapy. This informational resource is designed to assist licensed healthcare practitioners in caring for their patients and/ or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. Heart 2 Heart of America does not assume any responsibility for any aspect of healthcare administered with the aid of information Heart 2 Heart of America compiles. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions, check with your doctor, nurse or pharmacist.